Provident Financial Services, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PFS research report →
Range $26 – $27
Price Chart
About the company
Provident Financial Services, Inc. functions as the parent company for Provident Bank, delivering a broad spectrum of financial products and services to individuals, families, and businesses across the United States. Its deposit offerings encompass various account types, including savings, standard and interest-bearing checking accounts, money market accounts, certificates of deposit, and IRA products.
- CEO
- Anthony J. Labozzetta
- IPO
- 2003
- Employees
- 1,842
- HQ
- Jersey City, NJ, US
Get TickerSpark's AI analysis on PFS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.09B
- P/E
- 9.87
- Fwd P/E
- 9.62
- PEG
- 0.28
- P/S
- 2.24
- P/B
- 1.06
- EV/EBITDA
- 11.67
- Div Yield
- 4.05%
- Gross Margin
- 63.16%
- Op Margin
- 28.85%
- Net Margin
- 22.66%
- ROE
- 11.00%
- ROIC
- 4.48%
Latest fiscal year · YoY change
- Revenue
- $1.38B+21.3%
- Gross Profit
- $866.82M+42.8%
- Op Income
- $408.16M
- Net Income
- $291.16M+152.0%
- EPS
- $2.23+112.4%
- OCF Growth
- +3.7%
- FCF Growth
- +1.3%
- 52W High
- $25.49
- 52W Low
- $17.69
- 50D MA
- $23.90
- 200D MA
- $21.80
- Beta
- 0.78
- RSI (14)
- 41
- Avg Volume
- 1.01M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Provident Financial Services posted a strong second quarter with record revenue, expanding margins, and raised full-year growth guidance despite a more competitive deposit backdrop.· July 30, 2026
- Q2 net income was $78 million, or $0.60 per diluted share; core net income was $80 million, or $0.61 per share.
- Record revenue reached $235 million, driven by record net interest income of $203 million and record noninterest income of $32 million.
- Loan growth was strong: $700 million of new commercial loan fundings, $1.1 billion year-to-date, and period-end loans up $398 million, while management now expects full-year loan and deposit growth at the high end of the range, or 5% to 6%.
- Credit stayed sound overall, with asset quality improving sequentially; excluding one senior housing relationship, nonperforming loans would have been 27 basis points of total loans.
- Management raised its noninterest income outlook for Q3 and Q4 to $29 million per quarter and said it still expects core ROA of 1.2% to 1.3% and mid-teens ROTCE.
Provident reported second-quarter net earnings of $78 million, or $0.60 per diluted share, and core net earnings of $80 million, or $0.61 per share. Annualized adjusted ROA was 1.27%, adjusted ROTCE was over 16%, and core PPNR reached a record $118 million. Revenue was a record $235 million, including record net interest income of $203 million and record noninterest income of $32 million. On a year-over-year basis, adjusted net income increased 11%, core PPNR increased 18%, and core earnings per share grew 17% in the first half of 2026 versus the same period last year. Net interest margin was 3.48% reported and 3.09% core, while core expenses were $116.9 million and the efficiency ratio improved to 49.8%. For guidance, management now expects loan and deposit growth to land at the high end of the initial range, or 5% to 6% full-year growth. They also raised Q3 and Q4 noninterest income guidance to $29 million per quarter from $28.5 million previously, expect full-year effective tax rate of about 28% to 28.25%, and continue to target core ROA of 1.2% to 1.3% with a mid-teens ROTCE.
Tony Labozzetta framed the quarter as evidence that Provident’s growth strategy is working, highlighting record revenues, improved profitability, and strong operating leverage. He emphasized commercial lending momentum, especially the $3.2 billion pipeline and the second straight quarter with both CRE and C&I pipelines above $1 billion, and said the company is focused on organic growth first, with M&A remaining selective and driven by cultural and strategic fit. He also stressed continued investments in deposits, digital, and AI, and said the core conversion remains on track for the Labor Day target.
Adriano Duarte highlighted record revenue of $235 million, core PPNR of $118 million, and a reported net interest margin of 3.48%, with core NIM at 3.09%. He said deposit costs declined 2 basis points sequentially to 1.92% overall, while interest-bearing deposit costs fell to 2.37%, but he expects deposit costs to rise 1 to 2 basis points over the next couple of quarters because of CD competition. He also said the company expects core NIM expansion of 1 to 2 basis points in the third and fourth quarters, reported NIM of roughly 3.45% to 3.50% for the rest of 2026, quarterly operating expenses of about $117 million to $119 million, and about $4.5 million of additional nonrecurring core-system upgrade charges over the rest of 2026. Tangible book value per share rose $0.39 to $16.42, the tangible common equity ratio increased to 8.6%, and there were over 2 million shares remaining on the buyback authorization, though no shares were repurchased in Q2.
Analysts focused on deposits, NIM, loan pricing, accretion, and M&A. Management said competition is much more intense on funding than on lending, with deposit costs likely rising modestly while back-book repricing and securities cash flows support margin expansion; on loans, management said it is not seeing irrational pricing yet. On accretion, Adriano clarified that the apparent quarter-to-quarter noise reflected balance-sheet adjustments and said the underlying loan book accretion should be about $36 million in 2027, while the reported adjustment to NIM is about 35 basis points. On M&A, Tony said it remains part of strategy but only selectively, with organic growth still the top priority.
The quarter showed broad momentum: record revenue, improving margins, stronger fee income, and solid capital generation. Management sounded confident that loan production, deposit initiatives, and fee businesses such as insurance, wealth, and SBA sales can keep contributing, while the problematic senior housing credit is still expected to resolve with no material loss.
The biggest near-term headwind is deposit competition, especially for CDs and other incremental funding, and management expects deposit costs to rise modestly. Credit is mostly healthy, but the company still has a large senior housing relationship in workout and a CRE concentration ratio of 399% adjusted for purchase accounting marks, which keeps asset-quality and concentration risks in view.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 96.9%
- Shares Outstanding
- 130.31M
- Float Shares
- 126.28M
of shares held by institutions
306 13F filers
Buy/sell ratio 1.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for PFS, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Pat ToomeySenate · PA | Sell | Jan 5, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Jan 8, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Jan 5, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Jan 8, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Jan 8, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Jan 5, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Jan 8, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Jan 5, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Jan 8, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Jan 5, 18 | Filing → |
| Pat ToomeySenate · PA | Sell | Feb 11, 15 | Filing → |
| Pat ToomeySenate · PA | Sell | Nov 22, 16 | Filing → |
| Pat ToomeySenate · PA | Sell | Aug 7, 15 | Filing → |
| Pat ToomeySenate · PA | Sell | Aug 10, 15 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 19.24M | ▼ 78.76K |
| Vanguard Group Inc | 14.27M | ▼ 192.22K |
| Dimensional Fund Advisors LP | 8.17M | ▲ 103.03K |
| State Street Corp | 8.04M | ▲ 762.43K |
| Vanguard Capital Management LLC | 5.64M | ▲ 35.33K |
| American Century Companies Inc | 4.29M | ▲ 704.90K |
| Geode Capital Management, LLC | 3.49M | ▲ 171.23K |
| Wellington Management Group Llp | 3.10M | ▼ 2.69M |
| Millennium Management LLC | 2.30M | ▲ 2.25M |
| Systematic Financial Management LP | 1.87M | ▼ 84.90K |
| Charles Schwab Investment Management Inc | 1.62M | ▲ 2.98K |
| Sixth Street Partners Management Company, L.P. | 1.62M | ▲ 1.62M |
Held by 360 ETFs
Biggest fund positions in PFS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 18, 26 | Giannola Vito | sell | 20,000 |
| Aug 7, 26 | Regan Michael Edward | other | 3,066 |
| Jul 30, 26 | Gigliotti Diane | other | 0 |
| Jul 30, 26 | Regan Michael Edward | other | 0 |
| Jun 12, 26 | LISTA GEORGE | sell | 3,528 |
| Jun 1, 26 | Vitelli Annamaria | other | 0 |
| May 26, 26 | LEPPERT EDWARD J | other | 4,012 |
| May 26, 26 | SHARA THOMAS | other | 4,012 |
| May 26, 26 | MCCRACKEN ROBERT E | other | 4,012 |
| May 26, 26 | Foley Ursuline F | other | 4,012 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PFS coverage
Recent articles, reports, and earnings notes.
No research on PFS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PFS report →REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses
gurufocus.com · Aug 19
AstraZeneca Reports Positive Lung Cancer Trials Amid Pipeline Setback
gurufocus.com · Aug 17
Doubleview Gold Corp. Pursues Strategic Government Engagement Following US$400M U.S. Dept of War Scandium Funding Initiative
gurufocus.com · Aug 12
3 Savings & Loan Stocks Worth Picking on Improving Industry Prospects
zacks.com · Aug 10
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal
gurufocus.com · Aug 5
Provident Financial (PFS) is a Great Momentum Stock: Should You Buy?
zacks.com · Aug 5
Gilead Sciences Inc (GILD) (Q2 2026) Earnings Call Highlights: PrEP Sales Double to $1B, HIV Growth Accelerates, and Strategic Pipeline Advances
gurufocus.com · Aug 5
Provident Financial Services, Inc. and Provident Bank Promote Diane Gigliotti to Senior Vice President, Chief Accounting Officer
globenewswire.com · Aug 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.